Switch to
View more

Abbott India Ltd

ABBOTINDIA
Health CarePharmaceuticals
MidcapWith a market cap of ₹37,937 cr, stock is ranked 135
Low RiskStock is 1.61x as volatile as Nifty
17,620.00233.75 (-1.31%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹37,937 cr, stock is ranked 135
Low RiskStock is 1.61x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
47.50
PB RatioPB Ratio
13.45
Dividend YieldDiv. Yield
1.54%
Sector PESector PE
34.43
Sector PBSector PB
4.21
Sector Div YldSctr Div Yld
0.93%

Forecast & RatingsDetailed Forecast 

56%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Abbott India is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

Brands

Abbott India

Pharmaceutical company

Brands

Abbott India

Pharmaceutical company

Financial TrendFinancial statements 

20192020202120223.794.214.395.000.450.590.690.80
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings